Old Web
English
Sign In
Acemap
>
authorDetail
>
Scott M. Freeman
Scott M. Freeman
Regimen
Medicine
Head and neck squamous-cell carcinoma
cellular immunity
Cyclophosphamide
2
Papers
73
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Novel neoadjuvant immunotherapy regimen safety and survival in head and neck squamous cell cancer
2011
Head and Neck-journal for The Sciences and Specialties of The Head and Neck
Gregory T. Wolf
Willard E. Fee
Robert W. Dolan
Jeffrey S. Moyer
Michael Kaplan
Paul M. Spring
James Y. Suen
Daniel E. Kenady
Jason G. Newman
William R. Carroll
M. Boyd Gillespie
Scott M. Freeman
Lorraine Baltzer
Terry D. Kirkley
Harvey Brandwein
John W. Hadden
Show All
Source
Cite
Save
Citations (41)
A phase 1 safety study of an IRX-2 regimen in patients with squamous cell carcinoma of the head and neck.
2010
American Journal of Clinical Oncology
Scott M. Freeman
José Luis Barrera-Franco
Daniel E. Kenady
Lorraine Baltzer
Zygmund Roth
Harvey Brandwein
John W. Hadden
Show All
Source
Cite
Save
Citations (32)
1